Table 3 CMRs/100 PY (95% CI) during OAT, stratified by age, OAT medication and gender
PY in OAT (%) | Deaths, n (%) | CMR/100 PY (95% CI) | Drug-induced cause of death | Somatic cause of death | Violent cause of death | |
|---|---|---|---|---|---|---|
2014 | 7220 | 95 (48) | 1.3 (1.1–1.6) | NA | NA | NA |
2015 | 7439 | 105 (52) | 1.4 (1.2–1.7) | NA | NA | NA |
Total | 14,659 | 200 | 1.4 (1.2–1.6) | 0.6 (0.5–0.7) | 0.6 (0.5–0.8) | 0.2 (0.1–0.2) |
Age | ||||||
< 41 years | 5570 (38) | 33 (17) | 0.6 (0.4–0.8) | 0.3 (0.2–0.5) | 0.1 (0.1–0.2) | 0.2 (0.1–0.3) |
41–50 years | 5424 (37) | 81 (41) | 1.5 (1.2–1.9) | 0.7 (0.5–0.9) | 0.7 (0.5–0.9) | 0.2 (0.1–0.3) |
> 50 years | 3665 (25) | 86 (43) | 2.4 (1.9–2.9) | 0.8 (0.6–1.2) | 1.4 (1.0–1.8) | 0.1 (0.0–0.3) |
OAT medication | ||||||
Methadone | 5707 (39) | 109 (55) | 1.9 (1.6–2.3) | 0.8 (0.6–1.1) | 0.9 (0.7–1.2) | 0.2 (0.1–0.4) |
Buprenorphine | 8487 (58) | 82 (41) | 1.0 (0.8–1.2) | 0.4 (0.3–0.6) | 0.4 (0.3–0.6) | 0.1 (0.1–0.2) |
Gender | ||||||
Male | 10,261 (70) | 147 (73) | 1.4 (1.2–1.7) | 0.6 (0.4–0.7) | 0.7 (0.5–0.9) | 0.2 (0.1–0.3) |
Female | 4398 (30) | 53 (27) | 1.2 (0.9–1.6) | 0.6 (0.4–0.8) | 0.5 (0.3–0.7) | 0.2 (0.1–0.3) |